Aegros
Zhan Yang is a highly skilled engineering professional with extensive experience in process design and validation. Currently serving as a Process Design Engineer/Senior Validation Engineer at Aegros since May 2022, Zhan has demonstrated expertise in various roles across prominent companies. Zhan's previous positions include Process Engineer at MSD and Senior Production Engineer at Cochlear, contributing to key projects such as the introduction and validation of a new sterilizer and the Cochlear Sterilization process parametric release. Additional experience includes significant roles at Century 3 (Shanghai) Inc., China Haisum Engineering Co., Ltd., NNE Pharmaplan, and M+W Group, with involvement in major projects including the Cochlear China Expansion Project and the AstraZeneca Broad Market Project. Zhan holds a Bachelor of Science degree in Fine Chemical Engineering from Shanghai University of Engineering Science, completed in 2008.
This person is not in the org chart
This person is not in any teams
Aegros
At Aegros we believe access to life saving therapeutic plasma drugs is a human right and not a privilege. Our mission is to put the patient first through innovation and we do this thanks to our Australian invented Haemafrac®, Aegros' unique electroseparation process. Our TGA GMP-approved plasma fractionation plant in Macquarie Park, Sydney, manufactures a hyperimmune immunoglobulin product against Covid-19, made from convalescent plasma. Aegros is currently undertaking the final preparations for the submission of a dossier for the registration of this hyperimmune against Covid-19 on the Australian Register of Therapeutic Goods (ARTG) Simultaneously, Aegros is finishing the upgrade of its existing hyperimmune facility at Macquarie Park NSW to be able to process 100,000l of plasma per year.